RRC ID 44100
著者 Raveendran S, Poulose AC, Yoshida Y, Maekawa T, Kumar DS.
タイトル Bacterial exopolysaccharide based nanoparticles for sustained drug delivery, cancer chemotherapy and bioimaging.
ジャーナル Carbohydr Polym
Abstract Introduction of a novel biocompatible, stable, biomaterial for drug delivery application remains always challenging. In the present study, we report the synthesis of an extremophilic bacterial sulfated polysaccharide based nanoparticle as a stable biocompatible material for drug delivery, evaluation of anticancer efficacy and bioimaging. Mauran (MR), the sulfated exopolysaccharide extracted from a moderately halophilic bacterium, Halomonas maura was used for the synthesis of nanoparticles along with chitosan (CH). MR/CH nanoparticles were synthesized by simple polyelectrolyte complexation of anionic MR and cationic CH. The MR/CH hybrid nanoparticles formed were ranging between 30 and 200 nm in diameter with an overall positive zeta potential of 27.5±5 mV and was found to be stable under storage in solution for at least 8 weeks. In vitro drug release studies showed a sustained and prolonged delivery of 5-fluorouracil (5FU) for 10-12 days from MR/CH nanoparticles under three different pHs of 4.5, 6.9 and 7.4 respectively. Cytotoxicity assay revealed that MR/CH nanoparticles were non-cytotoxic towards normal cells and toxic to cancer cells. Also, 5FU loaded MR/CH nanoparticles were found more effective than free 5FU in its sustained and controlled manner of killing breast adenocarcinoma cells. Fluorescein isothiocyanate (FITC) labeled MR/CH nanoparticles were used for cell binding and uptake studies; thereby demonstrating the application of dye tagged MR/CH nanoparticles for safe and nontoxic mode of live cellular imaging. We report the introduction of an extremophilic bacterial polysaccharide, MR, for the first time as a novel biocompatible and stable biomaterial to the world of nanotechnology, pharmaceutics and biomedical technology.
巻・号 91(1)
ページ 22-32
公開日 2013-1-2
DOI 10.1016/j.carbpol.2012.07.079
PII S0144-8617(12)00752-7
PMID 23044101
MeSH Animals Antineoplastic Agents / chemistry Antineoplastic Agents / pharmacology* Biocompatible Materials / chemistry* Cell Line, Tumor Chemistry, Pharmaceutical Drug Carriers / chemistry* Fluorouracil / chemistry Fluorouracil / pharmacology Halomonas / chemistry Halomonas / ultrastructure Humans Kinetics Mice Microscopy, Electron, Scanning Molecular Imaging* Nanoparticles / chemistry* Polysaccharides, Bacterial / chemistry*
IF 7.182
引用数 42
WOS 分野 CHEMISTRY, APPLIED POLYMER SCIENCE CHEMISTRY, ORGANIC
リソース情報
ヒト・動物細胞 MCF7(RCB1904) L929